The article reports on the American Society for Radiation Oncology's (ASTRO) cancer study, which revealed that men with early stage prostate cancer can have an increased chance of living longer through short-term hormone therapy prior to and during intermediate dose radiation treatment. According to...
The “potent synergy” between radiation and hormone therapy may be key to the combined treatment’s promise, said Dr. Tang. “Hormone therapy has been shown in multiple studies to synergize with radiation therapy to reduce prostate cancer cells’ ability to repair themselves from radi...
Men who undergo hormone therapy typically experience hot flashes, low libido, weak bones and possibly diarrhea and nausea. What Causes Cancer? Unlikely Claims Explained View All 7 Slides Tags: cancer, prostate cancer, men's health, radiation, surgery, erectile dysfunction, health, patients, patient...
Prostate cancer patients who receive hormone treatments before undergoing three-dimensional conformal radiation therapy (3D-CRT) do not have increased side effects compared with those not receiving hormone therapy before radiation, according to a new study in the International Journal of Radiation Oncology...
In terms of adding radiation and a radiopharmaceutical, we thought that was very novel in that we are not using systemic treatment. So, it is an option for [patients] who do not want as much systemic treatment and who want a break from the hormone therapy, or who do not want the ...
The "potent synergy" between radiation and hormone therapy may be key to the combined treatment's promise, said Dr. Tang. "Hormone therapy has been shown in multiple studies to synergize with radiation therapy to reduce prostate cancer cells' ability to repair themselves from radiation-induced DNA...
深入研究「The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy」主題。共同形成了獨特的指紋。 引用此 APA Standard Harvard Vancouver Author BIBTEX RIS Wu, C. T., Chen, W. C., Liao, S. K., Hsu, C. L., Lee, K. D., & Chen, M. F....
In the randomized study of 1,205 men to investigate appropriate treatment for high-risk prostate cancer, half the participants received androgen deprivation therapy ("hormone therapy") alone and half received hormone therapy plus radiation. After seven years, 66 percent of men who had hormone therap...
Radiation Plus Hormone Therapy Extends Survival in Patients With High-Risk Prostate CancerAlice Goodman
Lawton CA, DeSilvio M, Roach M 3rd et al (2007) An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat...